QNTA
QNTA company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
16 articles
Price performance
Recent trading
Newsroom
Latest QNTA coverage
Medolife Rx Schedules Conference Call with Investment Community To Discuss Third Quarter 2021 Financial and Operational Results and New Updates
[ad_1] Burbank, CA – (NewMediaWire) – November 19, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has scheduled a conference call with investors for Tuesday,
Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products, Recaps Previous Results
[ad_1] Burbank, CA – (NewMediaWire) – October 06, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has initiated a study on its polarized cannabidiol (CBD
Medolife Rx Launches Ad Campaign With Tony Hawk, Sees Immediate Positive Results
[ad_1] Burbank, CA – (NewMediaWire) – September 23, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today the successful launch of a digital advertising campaign for its
Medolife Rx Recaps Successful Attendance at Tony Hawk Event; Saw Significant Product Exposure
[ad_1] Burbank, CA – (NewMediaWire) – September 1, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), today recapped their attendance at the Inaugural Tony Hawk’s Vert Alert event in
Medolife Rx Schedules Investor Webcast for Tuesday, July 27, 2021
[ad_1] BURBANK, CA – (NewMediaWire) – July 21, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it will hold a webcast and Q&A with the investment community on
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
[ad_1] Burbank, CA – (NewMediaWire) – July 08, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today new clinical observations made on its lead drug candidate Escoz
Medolife Rx Announces Successful Stability Results on Escozine Conjugated With Radioactive Iodine
[ad_1] BURBANK, CA – (NewMediaWire) – July 01, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that the Company has completed a stability study on its lead dr
Medolife Rx Signs Product Endorsement Agreement With Legendary Skateboarder Tony Hawk
[ad_1] Burbank, CA – (NewMediaWire) – June 17, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer products, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that the Company has entered into a major brand endorsement agreement with the le
Medolife Rx Provides Comment on Business in Lieu of Webcast Scheduled for June 8, 2021
[ad_1] Burbank, CA – (NewMediaWire) – June 08, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), today released the following statement from management regarding
Medolife Rx Schedules Investor Webcast for Tuesday June 8, 2021
[ad_1] Burbank, CA – (NewMediaWire) – June 3, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it will hold a webcast with the investment co
Medolife Rx Successfully Produces Medical Batch of Escozine Through In-house Facilities, Ready for Submission to DR Ministry of Health for Further Trials
[ad_1] Burbank, CA – (NewMediaWire) – May 27, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it successfully produced a pharmaceutical-quality batch of its le
Medolife Rx (Quanta, Inc.) Reports Over $1 Million in Revenue in 2020 Year-End Filing, Comments on Operations
[ad_1] Burbank, CA – (NewMediaWire) – April 19, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), reported today its financial results from fiscal year 2020 in its annual filing wher
Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate
[ad_1] Burbank, CA – (NewMediaWire) – April 08, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today pre-clinical study results conducted at one of the leading cancer re
Medolife Rxs Lead Drug Candidate Escozine Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic
[ad_1] Burbank, CA – (NewMediaWire) – April 01, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that Dr. Ramón Feliz MD, PhD, an oncological surgeon practicing medi
Medolife Rx Completes Batch Production of Escozine for FDA Submission
[ad_1] Burbank, CA – (NewMediaWire) – March 25, 2021 – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it has completed production of a batch of its lead drug candida
Medolife Rx Announces CMW Media as Strategic Communications Firm
[ad_1] Burbank, CA – (NewMediaWire) – March 04, 2021 – Medolife Rx, Inc., ("Medolife") a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), today announced that the Company has appointed CMW Media, a creative and public relations agency specializing in emerging markets, as its strategic communications firm. In recent months, Medoli